Amputations for vascular insufficiency

Amputations in peripheral vascular disease.

Until the cause of organic occlusive vascular diseases is definitely estab­ lished, and prophylactic measures taken to prevent them; until lipid metabolism can be controlled to pre­ vent atherosclerotic plaques from ad­ hering to the intima of arteries; until thrombosis and embolism can be pre­ vented and it will be routine to excise arterial segments and replace them with homografts or plastic...

Amputations for Critical Leg Ischaemia -vascular Prevention and Outcome

Major amputations of the lower extremity for vascular disease.

I n t r o d u c t i o n D e s p i t e c o n t i n u i n g p r o g r e s s in v a s c u l a r s u r g e r y , s o m e 9 0 % of al l a m p u t a t i o n s of t h e l o w e r l i m b a r e sti l l b e i n g p e r f o r m e d for v a s c u l a r occ lu s ive d i s e a s e . G a n g r e n e t o o c a n b e e x t e n s i v e . A p a t i e n t c a n b e i n o p e r a b l e fo r v a s c u l a r s u r g...

Mitral Insufficiency of Pulmonary Vascular Lesions

Two cases of mitral insufficiency are reported. In 1 case the lesion was produced by rupture of the chordae tendineae of the posterior leaflet of the mitral valve. In the other case it was produced by fibrous adhesion of the posterior leaflet of the mitral valve to the underlying left ventricular wall, which occurred during healing of subacute bacterial endocarditis. Changes occurred in the pul...

Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Twelve patients with systemic sclerosis (SS) and severe Raynaud's phenomenon received infusions of prostaglandin E1 (PGE1) at a dose of 6-10 ng/kg/min, with either saline or 5% dextrose, for 72 hours in a single-blind cross-over study. The infusions were administered intravenously by centrally positioned catheters. Infusions were well tolerated with only mild side effects. Following the PGE1 in...